<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-043352</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Evolution of severe mitral regurgitation after optimization of pharmacological therapy in non-ischemic dilated cardiomyopathy</dc:title>
<dc:description xml:lang="en">In dilated cardiomyopathy, severe functional mitral regurgitation (MR) is associated with a poor prognosis. In 112 consecutive clinically stable patients with non-ischemic dilated cardiomyopathy, echocardiography identified 15 (14%) patients who had severe MR (age, 53±12 years; 80% male; left ventricular ejection fraction, 26 ± 8%). Existing medical treatment with ACE inhibitors and beta-blockers was increased up to the maximum tolerated doses. At 6 months, MR decreased by at least one grade in 13 (87%) patients (P =.001), as did the effective regurgitant orifice area (from 0.41 [0.05] mm² to 0.20 [0.15] mm²; P &lt; .001) and the jet area (from 13.6 [2.1] cm² to 7.4 [4.5] cm²; P&lt;.001). These changes correlated with an increase in left ventricular ejection fraction (from 26 [8]% to 35 [10]%, P=.009; r=0.60, P=.01) and a decrease in end-diastolic volume (from 168 [46] mL to 142 [72] mL, P=.04; r=0.59, P=.02). An improvement in New York Heart Association class was observed (from 2.7 [0.5] to 1.9 [0.7]; P &lt; .001). The severity of functional MR decreased after medical treatment was maximized. The decrease correlated with improvements in left ventricular systolic function</dc:description>
<dc:creator>Morena Valenzuela, Gonzalo de la</dc:creator>
<dc:creator>González Carrillo, Josefa</dc:creator>
<dc:creator>Pascual Figal, Domingo A</dc:creator>
<dc:creator>Ansaldo Ruiz, Pilar</dc:creator>
<dc:creator>Ruipérez Abizanda, Juan A</dc:creator>
<dc:creator>Valdés Chavarri, Mariano</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En la miocardiopatía dilatada, la insuficiencia mitral (IM) funcional grave se asocia con una peor situación clínica y pronóstica. De 112 pacientes consecutivos con miocardiopatía dilatada no isquémica, 15 (14%) presentaban IM grave funcional por ecocardiografía (53 ± 12 años, 80% varones, FEVI 26 ± 8%). Se optimizó el tratamiento previo hasta dosis máximas toleradas de un inhibidor de la enzima de conversión de la angiotensina (IECA) y un bloqueador beta. A los 6 meses disminuyó el grado de insuficiencia en 13 pacientes (87%) (p = 0,001), el área del orificio regurgitante efectivo (0,41 ± 0,05 frente a 0,20 ± 0,15 mm²; p &lt; 0,001) y del jet (13,6 ± 2,1 frente a 7,4 ± 4,5 cm²; p &lt; 0,001). Estos cambios se correlacionaron con una mayor FEVI (26 ± 8 frente a 35 ± 10%; p = 0,009; r = 0,60, p = 0,01) y un menor volumen telesistólico (168 ± 46 frente 142 ± 72 ml; p = 0,04; r = 0,59, p = 0,02). Se observó una mejoría de la clase NYHA (2,7 ± 0,5 frente a 1,9 ± 0,7; p &lt; 0,001). La IM funcional grave evolucionó hacia la mejoría tras la optimización máxima de IECA y bloqueadores beta, lo que parece correlacionar con una mejora de la función sistólica</dc:description>
<dc:source>Rev Esp Cardiol;59(2): 176-179, feb. 2006. tab</dc:source>
<dc:identifier>ibc-043352</dc:identifier>
<dc:title xml:lang="es">Evolución de la insuficiencia mitral severa tras optimización del tratamiento médico en la miocardiopatía dilatada no isquémica</dc:title>
<dc:subject>^d2355^s22012</dc:subject>
<dc:subject>^d2355^s22057</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d9133^s22012</dc:subject>
<dc:subject>^d9133^s22057</dc:subject>
<dc:subject>^d31868^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d18001</dc:subject>
<dc:type>article</dc:type>
<dc:date>200602</dc:date>
</metadata>
</record>
</ibecs-document>
